Streamlining Cell Therapy Delivery With Efficiency-Led Design

There’s now concerted effort to reduce emissions in the cell therapy supply chain. Reducing CO₂ emissions can drive efficiency in supply chains, increasing the profitability and sustainability of business models, and help remove redundancy in cell therapy shipping and manufacturing processes.

Cold-chain logistics is one of the most carbon-intensive aspects of cell therapy manufacturing. Cytiva has shown that switching to a liquid nitrogen-free (LN₂-free) cryopreservation process can reduce CO₂ emissions by 87%, and cooling costs by > 95%.

This application note considers shipments within the cell therapy workflow, from initial patient sample to final cell therapy arrival at the patient’s side. Review how the VIA Capsule™ shipper helps reduce costs and carbon footprint for cell therapies.

By streamlining the delivery processes with efficiency-led design and smart logistics, manufacturers can reduce the financial costs of transport and CO₂ burden by 57%. The VIA Capsule™ shipper’s smart disinfection design reduces the number of required shipments for any given cell therapy manufacturing process.